How to Buy Genmab A Stock
Genmab A
Genmab A/S, a biopharmaceutical company founded in 1999 and headquartered in Copenhagen, Denmark, specializes in the discovery and development of innovative antibody therapies primarily for treating cancer and various other serious illnesses.
Genmab A stock last closed at $24.58, down 1.99% from the previous day, and has increased 7.52% in one year. It has overperformed other stocks in the Biotechnology industry by 0.79 percentage points. Genmab A stock is currently +21.53% from its 52-week low of $20.23, and -30.62% from its 52-week high of $35.43.
At the moment, there are 64.24M shares of GMAB outstanding. The market value of GMAB is $15.79B. In the last 24 hours, 1.02M GMAB shares were traded.
How to Buy Genmab A Stock
Wondering how to invest in Genmab A stock? Here's how.
- Decide where to buy Genmab A stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Genmab A stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Choose your payment method and add your details.
- Analyze Genmab A stock: The Genmab A ticker symbol is GMAB. Is Genmab A stock a good investment? Should you buy shares of GMAB? How do GMAB's underlying business fundamentals look? Do top analysts think Genmab A is a good buy? Why has GMAB's stock price moved recently? (Hint: Our stock market research website can help you decide if GMAB is a good stock to buy).
- Place your GMAB buy order: Decide if you will purchase GMAB shares at the current market price or use a limit order to buy GMAB stock at a specific price.
- Keep tabs on your GMAB investment: Create a watchlist to monitor your position in Genmab A shares.
Step 1: Decide where to buy Genmab A stock
You need an online brokerage account to access the NASDAQ market and buy GMAB shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal info so you can invest in GMAB today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new brokerage account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have created your account on the best stock app, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring funds into your brokerage account.
Step 4: Analyze Genmab A stock
Once you have decided on the best place to buy Genmab A stock, it's very important to research their stock prior to buying, so you actually comprehend the risk and opportunity.
Genmab A stock data
Genmab A Due Diligence Checks
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can view all of the due diligence checks on GMAB's stock page.
What is the fair value of GMAB stock?
You can use many financial metrics, analyses, models, and charts to gauge GMAB's intrinsic value.
Using relative valuations metrics:
- GMAB may be overvalued based on its P/E ratio of 18.43x, relative to Biotechnology industry P/E ratio of 16.41x
- GMAB could be undervalued based on its P/B ratio of 2.78x, relative to Biotechnology industry P/B ratio of 4.89x
- GMAB may be overvalued based on its PEG ratio of 11.72x
You can access additional valuation research on GMAB's stock here.
GMAB Financial Health Summary
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the GMAB balance sheet.
Negative Financial Indicators:
- There are more long-term liabilities than short-term assets on the GMAB balance sheet.
- GMAB profit margin has gone down from 35.1% to 21% in the past year.
- GMAB has a relatively high debt to equity ratio of 1.18.
- GMAB's operating cash flow of $902.00M allows it to safely service it's debt of $5.35B.
- Total GMAB debt is higher than 5 years ago, relative to shareholder equity.
- GMAB earnings of $1.41B is not sufficient to cover its interest payments.
Do analysts think it's a good time to buy GMAB stock
Out of 6 Equities analysts who give recommendations on GMAB, the consensus analyst rating on Genmab A is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent GMAB Analyst Recommendations
Judah Frommer, a bottom 7% analyst from Morgan Stanley reinstates GMAB with a hold rating and announces their GMAB price target of $34.00, on Feb 16, 2026.
You can dig deeper into what analysts are forecasting on the Genmab A stock forecast page.
Metrics for Advanced GMAB Traders
Is GMAB Making Money?
Last year, GMAB earnings were $821.00M. In the past five year, GMAB's earnings have gone up by 2.16% per year. This was slower than the Biotechnology industry average of 12.62%.
Last year, GMAB revenue was $3.90B. Over the past 5 year, GMAB's revenue has gone up by 20.87% per year. This was slower than the Biotechnology industry average of 32.3%.
You can research GMAB's earnings and revenue performance here.
What are GMAB executives and large shareholders up to?
Over the last year, insiders at GMAB have not bought or sold any shares.
Dig into more about who owns GMAB stock here.
Does GMAB stock generate passive income?
No, Genmab A doesn't provide an income stream by paying out dividends.
GMAB Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your GMAB buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price, use a limit order.
Click the Open button and eToro will place the order.
If you require more help buying stocks on eToro, click the how to video below:
Step 6: Keep tabs on your GMAB investment
Now that you own some GMAB stock, you'll want to keep up with your shares.
Make a watchlist to keep tabs on your GMAB stock.
GMAB Feed
How to Buy Stock in Genmab A
To reiterate, here are the 6 steps to buy stock in Genmab A:
- Decide where to buy Genmab A stock
- Create your brokerage account
- Deposit funds into your investment account
- Analyze Genmab A stock
- Place your GMAB buy order
- Keep tabs on your GMAB investment
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your investment in Genmab A, get started below.
More "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.